Journal of diabetes science and technology
Accelerating Transformation to a Digital-First Diabetes Care Model.
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
The YSI 2300 Analyzer Replacement Meeting Report.
The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial.
The Diabetes Technology Society Green Diabetes Initiative.
The Need for Precision Medicine to be Applied to Diabetes.
An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately.
The Need to Change Regulatory Evaluation of Hypoglycemia in Trials of Diabetes Treatments.
The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?
Predictors of Time-to-Repeat Point-of-Care Glucose Following Hypoglycemic Events in Hospitalized Patients.
